Contradictions in Corporate Social Responsibility
The pharmaceutical industry and medicines for the poor
As a response to the health crises in developing countries and the insufficient access to affordable drugs, around 90 of what are known as Global Public-Private Partnerships (GPPPs) have been set up over the last decade. Although these partnerships are varied, they all share some basic characteristics. They form collaborations or partnerships made up of a United Nations (UN) body such as the World Health Organization (WHO), national governments, corporations, foundations and non-governmental organisations (NGOs). The world’s largest pharmaceutical companies are also involved in these partnerships, and they provide drugs to the partnerships, usually at a reduced price or as a donation.
Partners
-
Wemos
Publicatie
Related news
-
Datahonger wint het van medisch beroepsgeheim in Europese wet voor gezondheidsdataGeplaatst in categorie:OpinieIrene SchipperIrene Schipper
-
Aandeelhouders boven klimaat: grote vervuilers maken liever winst dan klimaatplannen Gepubliceerd op:Ilona HartliefGeplaatst in categorie:PublicatieIlona Hartlief
-
Maatschappelijke organisaties roepen de EU op om de belangen van patiënten en burgers centraal te stellen in de European Health Data SpaceGeplaatst in categorie:Gepubliceerd op:Verklaring